Please login to the form below
IQVIA
This page shows the latest IQVIA news and features for those working in and with pharma, biotech and healthcare.
EFPIA pledges to boost drug access throughout Europe
Forecasts by IQVIA suggest that the commitment would increase the availability of medicines from 18% to 64% in several countries.
Latest news
-
Total COVID-19 vaccine spending to reach $157bn by 2025, says report
Total cumulative spending on COVID-19 vaccines is projected to reach $157bn by 2025, according to a new report from the IQVIA Institute for Human Data Science. ... the immediate effects of COVID-19,” said Murray Aitken, senior vice president of IQVIA
-
Biogen raises full year guidance after beating Q2 expectations
Replacing him at the helm is Mike McDonnell, who joins Biogen from contract research organisation IQVIA where he also served as chief financial officer.
-
EMA to support real-world monitoring of COVID-19 treatments/vaccines
Another contract, agreed in June, saw the EMA contract IQVIA to build a framework to support the conduct of multicentre cohort studies monitoring the use of a number of medicines in
-
PMEA 2019: Recognising excellence in improving patient outcomes
Takeda also won in three other categories: Excellence in Collaboration and Partnerships for A Gut Reaction with support from IQVIA, Excellence in Patient Education and Support for NINLARO Patient Support Programme
-
IQVIA and partners set up cancer ‘data hub’ to speed up research
The founding partners of the cancer data hub, called DATA-CAN, includes IQVIA, UCLPartners, Queen’s University Belfast, the University of Leeds and Leeds Teaching Hospitals and Genomics England. ... IQVIA will run the central database, and will use
More from news
Approximately 14 fully matching, plus 14 partially matching documents found.
Latest Intelligence
-
Merging global and local pharmacovigilance operations into a successful integrated approach
For more information, visit www.iqvia.com/globalcompliance. or download the fact sheet at www.iqvia.com/library/fact-sheets/local-affiliate-product-services. . ... Alisa Hummings is Global Head, CEVA and Medical Information and Pharmacovigilance at IQVIA.
-
Design considerations and best practices in clinical research
Gerd Rippin is Director Biostatistics, Real World Solutions at IQVIA. Gerd Rippin is Director Biostatistics, Real World Solutions at IQVIA. ... Gerd Rippin is Director Biostatistics, Real World Solutions at IQVIA. 5th January 2023.
-
Looking to the future of patient empowerment
So what are PSPs? This is an umbrella term applied to initiatives generally led by pharmaceutical companies to ‘improve access and adherence to prescription drugs’ (IQVIA white paper, 2021) or a
-
Expanding clinical trial access: a global imperative requiring local focus
hesitancy. IQVIA also staffed sites with culturally trained personnel to enhance diversity in patient and caregiver engagement. ... Pankaj Patel is Head of Diversity and Inclusion, Research and Development Solutions at IQVIA.
-
Patient-centricity and how HCPs can help achieve better patient outcomes through collaboration
Within IQVIA Pathway Transformation, we have helped clinical and service teams across the UK address unwarranted variation and inefficiencies. ... Pathway transformation experts at IQVIA regularly work with NHS teams, patient representatives and patient
More from intelligence
Approximately 4 fully matching, plus 26 partially matching documents found.
Latest appointments
-
Research Partnership announces new CEO Gareth Phillips
Phillips joins the company with a wealth of global experience, having spent 25 years in healthcare market research working with IMS Health – now IQVIA – and Synovate Healthcare, before it was acquired
-
Ashfield Engage taps Keith Buckby as UK business development director
Prior to returning to Ashfield, Buckby completed a two-year stint at IQVIA, where he most recently held the role of business development director.
-
Research Partnership appoints Hannah Osborn to MedTech director role
Osborne has previously worked at Ipsos and IQVIA. Research Partnership has appointed Hannah Osborn as a MedTech director in its London, UK office. ... Previously, she worked for Ipsos as director for its MedTech Asia-Pacific (APAC) team, and for IQVIA as
-
Immunocore names new CEO, Nanoform adds to commercial team and Verona hires CMO
Prior to joining Verona Pharma, she was a strategic drug development leader at IQVIA where she helped pharmaceutical companies develop integrated commercial and R&D strategies.
-
Parexel appoints CEO
He has also served as senior vice president and head of global project management at Quintiles, now IQVIA.
More from appointments
Approximately 0 fully matching, plus 5 partially matching documents found.
Latest from PMHub
-
Research Partnership appoints new CEO
He brings with him a wealth of global experience, having spent 25 years in healthcare market research working with IMS Health (now IQVIA) and Synovate Healthcare before it was acquired by
-
Stick or twist? The future of HCP engagement
Even HCPs report that they are happy to supplement face-to-face time with increased remote engagement ( IQVIA, 2020). ... For example, research by IQVIA suggests HCPs who are used to regular F2F meetings would still like them to continue in the future,
-
Envision Pharma Group appoints Manish Goel as Global Head of Envision Technology Solutions
Goel will drive the development of innovative technologies, and joins Envision from IQVIA where he served as the VP of Technology Solutions. ... Manish Goel brings over 15 years of leadership experience across the technology and healthcare sphere, and
-
Healthcare agency Page & Page and Partners welcomes wave of new talent
Novartis, Abbott Diagnostics, Fresenius Kabi, L&R, Align Technology and IQVIA.
-
The concordance conundrum: the value of improving patient experience
Figures from IQVIA Consumer Health (pre-COVID-19) already illustrated that HCPs are responding positively to remote engagement with overall satisfaction with these projects ranging from 91%-95% (See Figures 1,
More from PMHub
Approximately 0 fully matching, plus 9 partially matching documents found.
Subscribe to our email news alerts
-
Pharmacovigilance Manager
- Highly competitive salary
-
Pharmacovigilance Project Lead
- Highly competitive salary
- Early Access Program - Regulatory Affairs (EAP-RA)
- Highly competitive salary
- Associate Director - Global Healthcare Consulting
- £100,000 - £115,000 yearly
-
Senior Medical Writer
- Highly competitive salary
- Strategy Director - Healthcare Advertising
- £90,000 - £120,000 yearly
-
Omnichannel Account Director
- £55,000 - £65,000 yearly
-
Technical Sales Representative
- Highly competitive salary
- AbbVie’s Parkinson’s disease therapy application rejected by FDA
- MHRA to introduce new UK clinical trials framework
- FDA proposes improvements for oncology clinical trials supporting accelerated approval
- Roche and Eli Lilly to collaborate on Alzheimer’s disease blood test
- Novo Nordisk and Dewpoint partner on insulin resistance drug candidates
- Takeda presents positive phase 2b results for TAK-279 in plaque psoriasis
- MSD’s Keytruda to be made available in England for advanced cervical cancer patients
- Boehringer Ingelheim and Covant to collaborate on cancer immunotherapies
- Eli Lilly increases investment to almost $1bn for new Irish manufacturing facility
- Regeneron and Sonoma Biotherapeutics partner on autoimmune disease therapies
- Improving cardiovascular disease care and awareness
- PMGroup announces launch of new recruitment platform PharmaRole
- Locus Biosciences announces first patient treated in urinary tract infection trial
- Team ITG appoints Gerhard Arnhofer as head of customer strategy for life sciences division
- The state of pharma customer experience
- Merck reports positive results for Keytruda plus chemotherapy in endometrial cancer
- MHRA to introduce new UK clinical trials framework
- Takeda presents positive phase 2b results for TAK-279 in plaque psoriasis
PMHub
Fishawack Health
Established in 2001, Fishawack Health (FH) is a purposefully built commercialization partner for the biopharmaceutical, medical technology, and wellness industries....
Latest intelligence
- Improving cardiovascular disease care and awareness
- Scott Curley talks to PME about the risks of CVD and the importance of getting the right treatment at the right time...
- Virtual Patient Engagement Program: A Customer Story
- Our client wanted to better understand the needs, preferences, and treatment gaps among adult patients with a rare genetic disease......
- Humancomms for humancare?
- Paul Hutchings, founder of fox&cat, writes on the role of humour in healthcare comms: PharmaComms 2023...
